Home News Page 65

News

Heidelberg and Roche Extend Development Agreement

Heidelberg Pharma GmbH, a wholly owned subsidiary of Wilex AG based in Ladenburg, Germany, and Swiss drugmaker F. Hoffmann-La...

Bicycle Therapeutics Secures Equity Financing for Clinical Development Program

Bicycle Therapeutics, a next generation biotherapeutics company developing first-in-class bicyclic peptides, has secured an equity financing of £20 (US...

The Growing Field of Immunoconjugates – How to Successfully Link Antibodies and Small Cytotoxic...

The recent FDA approvals of brentuximab vedotin (Adcetris®; Seattle Genetics) andtrastuzumab emtansine (Kadcyla®; Genentech/Roche), show that antibody-drug conjugates are indeed becoming an important...

Broad Patent For Antibody Development

The United States Patent and Trademark Office (USPTO) has issued Patent No. 8,859,467, to BioAtla (San Diego, California, and...

Development of an Antibody-Drug Conjugates with Improved Therapeutic Activity Through Linker and Antibody Engineering

Antibody-drug conjugates or ADCs have a significant impact on the treatment of cancer. This is demonstrated by the clinical...

Conjugation Effects on Antibody–Drug Conjugates

Antibody-drug conjugates or ADC have shown promising effects in cancer therapy by combining the target specificity of an antibody...

Catalent receives 11th annual CPhI live Pharma Award

CPhI Worldwide, organized by UBM Live, announced the winners of the 11th annual CPhI live Pharma Awards. The annual...

Ongoing Development of Inotuzumab Ozogamicin in Hematological Malignancies

The mechanism of action of calicheamicin, a DNA-damaging agent that, following intracellular activation, binds to DNA in the minor...

Oxford BioTherapeutics and Berlin Chemie Develop New Antibody-Drug Conjugate as Second Clinical Development Candidate...

Oxford BioTherapeutics, a biopharmaceutical company developing a range of innovative antibody-drug conjugates or ADCs based on the company's proprietary...

Catalent Pharma Solutions Inc. acquires Redwood Bioscience Inc

Leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, Catalent Pharma...